RTW Investments, LP 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:49 am Sale |
2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 0 0.000% |
-2,067,824 (Position Closed) |
Filing |
| 2023-02-14 10:10 am Sale |
2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 2,067,824 6.900% |
-118,500 (-5.42%) |
Filing |
| 2022-02-14 08:43 am Purchase |
2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 2,186,324 7.900% |
673,651 (+44.53%) |
Filing |
| 2021-02-12 09:38 am Purchase |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RTW Investments, LP | 1,512,673 9.310% |
256,816 (+20.45%) |
Filing |